ANA Investigates Cannabis and Cannabinoids for MS Symptoms

Published in partnership with American Neurological Association

In this podcast, Michelle Cameron, MD, PT, talks about the federal and state legalities surrounding cannabinoid use, how cannabinoids go through the FDA approval process, and how cannabinoids can be used to treat symptoms of multiple sclerosis.

Michelle Cameron

Michelle Cameron, MD, PT, MCR, is associate professor of neurology at the  Oregon Health & Science University in Portland, Oregon.

For more ANA investigates podcasts, visit our partners at the American Neurological Association.